{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:03:38Z","timestamp":1791338618630,"version":"4.3.1"},"update-to":[{"DOI":"10.1371\/journal.pgen.1009009","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T00:00:00Z","timestamp":1604275200000}}],"reference-count":111,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T00:00:00Z","timestamp":1603238400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["5P01AI131294-03"],"award-info":[{"award-number":["5P01AI131294-03"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI145038"],"award-info":[{"award-number":["AI145038"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosgenetics.org"],"crossmark-restriction":false},"short-container-title":["PLoS Genet"],"DOI":"10.1371\/journal.pgen.1009009","type":"journal-article","created":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T13:37:13Z","timestamp":1603287433000},"page":"e1009009","update-policy":"https:\/\/doi.org\/10.1371\/journal.pgen.corrections_policy","source":"Crossref","is-referenced-by-count":43,"title":["Predominance of positive epistasis among drug resistance-associated mutations in HIV-1 protease"],"prefix":"10.1371","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4422-5581","authenticated-orcid":true,"given":"Tian-hao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P.","family":"Barton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8015-4207","authenticated-orcid":true,"given":"Yushen","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1704-1293","authenticated-orcid":true,"given":"Yuxiang","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arup K.","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7941-502X","authenticated-orcid":true,"given":"James O.","family":"Lloyd-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1624-4857","authenticated-orcid":true,"given":"Ren","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,10,21]]},"reference":[{"issue":"13","key":"pgen.1009009.ref001","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection","volume":"338","author":"FJ Palella","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"pgen.1009009.ref002","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1310\/hct0805-282","article-title":"Effect of adherence to HAART on virologic outcome and on the selection of resistance-conferring mutations in NNRTI-or PI-treated patients","volume":"8","author":"F Maggiolo","year":"2007","journal-title":"HIV Clinical Trials"},{"issue":"Supplement_1","key":"pgen.1009009.ref003","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1086\/505356","article-title":"Rationale and Uses of a Public HIV Drug-Resistance Database","volume":"194","author":"RW Shafer","year":"2006","journal-title":"The Journal of Infectious Diseases"},{"key":"pgen.1009009.ref004","first-page":"34","article-title":"Mechanisms of antibiotic resistance","volume":"6","author":"J Lin","year":"2015","journal-title":"Frontiers in Microbiology"},{"issue":"5","key":"pgen.1009009.ref005","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/hep.27934","article-title":"Hepatitis C virus drug resistance\u2013associated substitutions: state of the art summary","volume":"62","author":"E Lontok","year":"2015","journal-title":"Hepatology"},{"issue":"1","key":"pgen.1009009.ref006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-3542(00)00103-0","article-title":"Resistance of influenza viruses to neuraminidase inhibitors\u2014a review","volume":"47","author":"JL McKimm-Breschkin","year":"2000","journal-title":"Antiviral Research"},{"issue":"5","key":"pgen.1009009.ref007","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2165\/00003495-199754050-00002","article-title":"Antifungal resistance trends towards the year 2000","volume":"54","author":"BD Alexander","year":"1997","journal-title":"Drugs"},{"issue":"9312","key":"pgen.1009009.ref008","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0140-6736(02)08162-X","article-title":"Antifungal drug resistance of pathogenic fungi","volume":"359","author":"DP Kontoyiannis","year":"2002","journal-title":"The Lancet"},{"key":"pgen.1009009.ref009","unstructured":"on Antimicrobial Resistance R. Tackling drug-resistant infections globally: final report and recommendations. Review on Antimicrobial Resistance; 2016."},{"key":"pgen.1009009.ref010","unstructured":"Forum WE. The Global Risks Report 2018, 13th Edition. World Economic Forum; 2018."},{"issue":"1","key":"pgen.1009009.ref011","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/nrmicro3380","article-title":"Molecular mechanisms of antibiotic resistance","volume":"13","author":"JM Blair","year":"2015","journal-title":"Nature Reviews Microbiology"},{"issue":"2","key":"pgen.1009009.ref012","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1177\/135965350701200202","article-title":"Improved prediction of response to antiretroviral combination therapy using the genetic barrier to drug resistance","volume":"12","author":"A Altmann","year":"2007","journal-title":"Antiviral Therapy"},{"key":"pgen.1009009.ref013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virusres.2016.07.006","article-title":"Clinical benefit of dolutegravir in HIV-1 management related to the high genetic barrier to drug resistance","volume":"239","author":"BG Brenner","year":"2017","journal-title":"Virus Research"},{"issue":"3","key":"pgen.1009009.ref014","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1177\/135965350801300316","article-title":"Modelled in vivo HIV fitness under drug selective pressure and estimated genetic barrier towards resistance are predictive for virological response","volume":"13","author":"K Deforche","year":"2008","journal-title":"Antiviral Therapy"},{"issue":"2","key":"pgen.1009009.ref015","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/jmv.2023","article-title":"Replicative fitness in vivo of HIV-1 variants with multiple drug resistance-associated mutations","volume":"65","author":"HL Devereux","year":"2001","journal-title":"Journal of Medical Virology"},{"issue":"5","key":"pgen.1009009.ref016","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1369-5274(99)00005-3","article-title":"The biological cost of antibiotic resistance","volume":"2","author":"DI Andersson","year":"1999","journal-title":"Current Opinion in Microbiology"},{"issue":"4","key":"pgen.1009009.ref017","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/nrmicro2319","article-title":"Antibiotic resistance and its cost: is it possible to reverse resistance?","volume":"8","author":"DI Andersson","year":"2010","journal-title":"Nature Reviews Microbiology"},{"issue":"5","key":"pgen.1009009.ref018","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.coviro.2012.08.004","article-title":"The distinct contributions of fitness and genetic barrier to the development of antiviral drug resistance","volume":"2","author":"M G\u00f6tte","year":"2012","journal-title":"Current Opinion in Virology"},{"issue":"1","key":"pgen.1009009.ref019","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1742-4690-10-22","article-title":"Viral fitness cost prevents HIV-1 from evading dolutegravir drug pressure","volume":"10","author":"T Mespl\u00e8de","year":"2013","journal-title":"Retrovirology"},{"issue":"12","key":"pgen.1009009.ref020","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S1471-4922(01)02185-7","article-title":"Pyrimethamine\u2013sulfadoxine resistance in Plasmodium falciparum: what next?","volume":"17","author":"CH Sibley","year":"2001","journal-title":"Trends in Parasitology"},{"issue":"17","key":"pgen.1009009.ref021","doi-asserted-by":"crossref","first-page":"9068","DOI":"10.1128\/JVI.00340-15","article-title":"HIV-1 resistance to the capsid-targeting inhibitor PF74 results in altered dependence on host factors required for virus nuclear entry","volume":"89","author":"J Zhou","year":"2015","journal-title":"Journal of Virology"},{"issue":"10","key":"pgen.1009009.ref022","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1110\/ps.0206702","article-title":"Drug resistance in HIV-1 protease: flexibility-assisted mechanism of compensatory mutations","volume":"11","author":"S Piana","year":"2002","journal-title":"Protein Science"},{"issue":"7","key":"pgen.1009009.ref023","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1056\/NEJM200102153440702","article-title":"Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia","volume":"344","author":"SG Deeks","year":"2001","journal-title":"New England Journal of Medicine"},{"issue":"14","key":"pgen.1009009.ref024","doi-asserted-by":"crossref","first-page":"6262","DOI":"10.1128\/JVI.74.14.6262-6268.2000","article-title":"Evolution of lamivudine resistance in human immunodeficiency virus type 1-infected individuals: the relative roles of drift and selection","volume":"74","author":"SD Frost","year":"2000","journal-title":"Journal of Virology"},{"issue":"9","key":"pgen.1009009.ref025","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1086\/496892","article-title":"Interruption of treatment with individual therapeutic drug classes in adults with multidrug-resistant HIV-1 infection","volume":"192","author":"SG Deeks","year":"2005","journal-title":"Journal of Infectious Diseases"},{"issue":"9","key":"pgen.1009009.ref026","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1038\/nm.2892","article-title":"Antiretroviral dynamics determines HIV evolution and predicts therapy outcome","volume":"18","author":"DI Rosenbloom","year":"2012","journal-title":"Nature Medicine"},{"issue":"17","key":"pgen.1009009.ref027","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1097\/00002030-199912030-00006","article-title":"Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy","volume":"13","author":"M Nijhuis","year":"1999","journal-title":"Aids"},{"issue":"5","key":"pgen.1009009.ref028","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1128\/AAC.01460-09","article-title":"Compensation of fitness costs and reversibility of antibiotic resistance mutations","volume":"54","author":"PS zur Wiesch","year":"2010","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"5","key":"pgen.1009009.ref029","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.resmic.2004.01.019","article-title":"Adaptation to the deleterious effects of antimicrobial drug resistance mutations by compensatory evolution","volume":"155","author":"S Maisnier-Patin","year":"2004","journal-title":"Research in Microbiology"},{"issue":"5701","key":"pgen.1009009.ref030","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1126\/science.1101786","article-title":"Evidence for positive epistasis in HIV-1","volume":"306","author":"S Bonhoeffer","year":"2004","journal-title":"Science"},{"issue":"5","key":"pgen.1009009.ref031","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/ng.795","article-title":"A systems analysis of mutational effects in HIV-1 protease and reverse transcriptase","volume":"43","author":"T Hinkley","year":"2011","journal-title":"Nature Genetics"},{"issue":"7","key":"pgen.1009009.ref032","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/pro.2897","article-title":"Epistasis in protein evolution","volume":"25","author":"TN Starr","year":"2016","journal-title":"Protein Science"},{"issue":"5701","key":"pgen.1009009.ref033","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1126\/science.1106677","article-title":"Epistasis in RNA viruses","volume":"306","author":"Y Michalakis","year":"2004","journal-title":"Science"},{"issue":"2","key":"pgen.1009009.ref034","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jmb.2009.07.015","article-title":"Epistasis among deleterious mutations in the HIV-1 protease","volume":"392","author":"M Parera","year":"2009","journal-title":"Journal of Molecular Biology"},{"issue":"22","key":"pgen.1009009.ref035","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1016\/j.cub.2014.09.072","article-title":"A comprehensive biophysical description of pairwise epistasis throughout an entire protein domain","volume":"24","author":"CA Olson","year":"2014","journal-title":"Current Biology"},{"issue":"1","key":"pgen.1009009.ref036","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/molbev\/msu301","article-title":"A systematic survey of an intragenic epistatic landscape","volume":"32","author":"C Bank","year":"2014","journal-title":"Molecular Biology and Evolution"},{"issue":"7603","key":"pgen.1009009.ref037","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nature17995","article-title":"Local fitness landscape of the green fluorescent protein","volume":"533","author":"KS Sarkisyan","year":"2016","journal-title":"Nature"},{"issue":"6","key":"pgen.1009009.ref038","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1469-0691.2011.03556.x","article-title":"Strain diversity, epistasis and the evolution of drug resistance in Mycobacterium tuberculosis","volume":"17","author":"S Borrell","year":"2011","journal-title":"Clinical Microbiology and Infection"},{"issue":"7","key":"pgen.1009009.ref039","doi-asserted-by":"crossref","first-page":"e1000578","DOI":"10.1371\/journal.pgen.1000578","article-title":"Positive epistasis drives the acquisition of multidrug resistance","volume":"5","author":"S Trindade","year":"2009","journal-title":"PLoS Genetics"},{"issue":"7","key":"pgen.1009009.ref040","doi-asserted-by":"crossref","first-page":"e1002181","DOI":"10.1371\/journal.pgen.1002181","article-title":"Pervasive sign epistasis between conjugative plasmids and drug-resistance chromosomal mutations","volume":"7","author":"RF Silva","year":"2011","journal-title":"PLoS Genetics"},{"issue":"3","key":"pgen.1009009.ref041","doi-asserted-by":"crossref","first-page":"e1004722","DOI":"10.1371\/journal.ppat.1004722","article-title":"Persistence of transmitted HIV-1 drug resistance mutations associated with fitness costs and viral genetic backgrounds","volume":"11","author":"WL Yang","year":"2015","journal-title":"PLoS Pathogens"},{"key":"pgen.1009009.ref042","article-title":"Evolution in the light of fitness landscape theory","author":"I Fragata","year":"2018","journal-title":"Trends in Ecology & Evolution"},{"issue":"6","key":"pgen.1009009.ref043","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1128\/JVI.02712-06","article-title":"The fitness cost of mutations associated with human immunodeficiency virus type 1 drug resistance is modulated by mutational interactions","volume":"81","author":"Me Cong","year":"2007","journal-title":"Journal of Virology"},{"issue":"5","key":"pgen.1009009.ref044","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1128\/JVI.73.5.3744-3752.1999","article-title":"Replicative fitness of protease inhibitor-resistant mutants of human immunodeficiency virus type 1","volume":"73","author":"J Martinez-Picado","year":"1999","journal-title":"Journal of Virology"},{"key":"pgen.1009009.ref045","first-page":"95","article-title":"HIV protease inhibitors: a review of molecular selectivity and toxicity","volume":"7","author":"Z Lv","year":"2015","journal-title":"HIV\/AIDS (Auckland, NZ)"},{"issue":"18","key":"pgen.1009009.ref046","doi-asserted-by":"crossref","first-page":"9571","DOI":"10.1073\/pnas.93.18.9571","article-title":"Apoptosis mediated by HIV protease is preceded by cleavage of Bcl-2","volume":"93","author":"PR Strack","year":"1996","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"5","key":"pgen.1009009.ref047","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nri1087","article-title":"Cell death and immunity: apoptosis as an HIV strategy to escape immune attack","volume":"3","author":"ML Gougeon","year":"2003","journal-title":"Nature Reviews Immunology"},{"issue":"2","key":"pgen.1009009.ref048","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/abbi.2001.2333","article-title":"The binding energetics of first-and second-generation HIV-1 protease inhibitors: implications for drug design","volume":"390","author":"A Velazquez-Campoy","year":"2001","journal-title":"Archives of Biochemistry and Biophysics"},{"issue":"3","key":"pgen.1009009.ref049","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1086\/427192","article-title":"Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy","volume":"191","author":"PR Harrigan","year":"2005","journal-title":"The Journal of Infectious Diseases"},{"issue":"7","key":"pgen.1009009.ref050","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1517\/17460441.3.7.775","article-title":"Second generation HIV protease inhibitors against resistant virus","volume":"3","author":"Z Lu","year":"2008","journal-title":"Expert opinion on drug discovery"},{"issue":"3","key":"pgen.1009009.ref051","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1089\/aid.2006.22.289","article-title":"Phenotypic drug resistance patterns in subtype A HIV-1 clones with nonnucleoside reverse transcriptase resistance mutations","volume":"22","author":"SH Eshleman","year":"2006","journal-title":"AIDS Research & Human Retroviruses"},{"issue":"3","key":"pgen.1009009.ref052","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1089\/aid.2007.0173","article-title":"Resistance profile of darunavir: combined 24-week results from the POWER trials","volume":"24","author":"S De Meyer","year":"2008","journal-title":"AIDS Research and Human Retroviruses"},{"issue":"21","key":"pgen.1009009.ref053","doi-asserted-by":"crossref","first-page":"11104","DOI":"10.1128\/JVI.76.21.11104-11112.2002","article-title":"Evolution of phenotypic drug susceptibility and viral replication capacity during long-term virologic failure of protease inhibitor therapy in human immunodeficiency virus-infected adults","volume":"76","author":"JD Barbour","year":"2002","journal-title":"Journal of Virology"},{"issue":"6","key":"pgen.1009009.ref054","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/89090","article-title":"Impaired replication of protease inhibitor-resistant HIV-1 in human thymus","volume":"7","author":"CA Stoddart","year":"2001","journal-title":"Nature Medicine"},{"issue":"5","key":"pgen.1009009.ref055","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1093\/jac\/dkh162","article-title":"Paradoxes of adherence and drug resistance to HIV antiretroviral therapy","volume":"53","author":"DR Bangsberg","year":"2004","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"pgen.1009009.ref056","doi-asserted-by":"crossref","unstructured":"Condra JH, Schleif WA, Blahy OM, Gabryelski LJ, Graham DJ, Quintero J, et al. In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors; 1995.","DOI":"10.1038\/374569a0"},{"issue":"3","key":"pgen.1009009.ref057","article-title":"Gag mutations strongly contribute to HIV-1 resistance to protease inhibitors in highly drug-experienced patients besides compensating for fitness loss","volume":"5","author":"E Dam","year":"2009","journal-title":"PLoS pathogens"},{"issue":"4","key":"pgen.1009009.ref058","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jmb.2011.03.038","article-title":"Accessory mutations maintain stability in drug-resistant HIV-1 protease","volume":"410","author":"MW Chang","year":"2011","journal-title":"Journal of molecular biology"},{"issue":"12","key":"pgen.1009009.ref059","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1089\/088922200414992","article-title":"HIV type 1 protease cleavage site mutations and viral fitness: implications for drug susceptibility phenotyping assays","volume":"16","author":"LH Robinson","year":"2000","journal-title":"AIDS research and human retroviruses"},{"issue":"4","key":"pgen.1009009.ref060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004249","article-title":"Deep sequencing of protease inhibitor resistant HIV patient isolates reveals patterns of correlated mutations in Gag and protease","volume":"11","author":"WF Flynn","year":"2015","journal-title":"PLoS computational biology"},{"issue":"10","key":"pgen.1009009.ref061","doi-asserted-by":"crossref","first-page":"4253","DOI":"10.1128\/AAC.00574-10","article-title":"HIV-1 protease mutations and protease inhibitor cross-resistance","volume":"54","author":"SY Rhee","year":"2010","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"4","key":"pgen.1009009.ref062","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1128\/JVI.76.4.1753-1761.2002","article-title":"Persistence and fitness of multidrug-resistant human immunodeficiency virus type 1 acquired in primary infection","volume":"76","author":"BG Brenner","year":"2002","journal-title":"Journal of Virology"},{"issue":"7","key":"pgen.1009009.ref063","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.1371\/journal.pmed.0050158","article-title":"Minority HIV-1 drug resistance mutations are present in antiretroviral treatment\u2013na\u00efve populations and associate with reduced treatment efficacy","volume":"5","author":"JA Johnson","year":"2008","journal-title":"PLoS Medicine"},{"issue":"12","key":"pgen.1009009.ref064","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1097\/01.aids.0000131391.91468.ff","article-title":"Persistence of primary drug resistance among recently HIV-1 infected adults","volume":"18","author":"JD Barbour","year":"2004","journal-title":"Aids"},{"issue":"6","key":"pgen.1009009.ref065","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/molbev\/msx095","article-title":"Inference of epistatic effects leading to entrenchment and drug resistance in HIV-1 protease","volume":"34","author":"WF Flynn","year":"2017","journal-title":"Molecular biology and evolution"},{"key":"pgen.1009009.ref066","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.50524","article-title":"Epistasis and entrenchment of drug resistance in HIV-1 subtype B","volume":"8","author":"A Biswas","year":"2019","journal-title":"eLife"},{"issue":"4","key":"pgen.1009009.ref067","doi-asserted-by":"crossref","first-page":"e1004064","DOI":"10.1371\/journal.ppat.1004064","article-title":"A quantitative high-resolution genetic profile rapidly identifies sequence determinants of hepatitis C viral fitness and drug sensitivity","volume":"10","author":"H Qi","year":"2014","journal-title":"PLoS Pathogens"},{"key":"pgen.1009009.ref068","doi-asserted-by":"crossref","first-page":"e16965","DOI":"10.7554\/eLife.16965","article-title":"Adaptation in protein fitness landscapes is facilitated by indirect paths","volume":"5","author":"NC Wu","year":"2016","journal-title":"Elife"},{"issue":"8","key":"pgen.1009009.ref069","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1128\/AAC.48.8.3122-3126.2004","article-title":"Distribution of human immunodeficiency virus type 1 protease and reverse transcriptase mutation patterns in 4,183 persons undergoing genotypic resistance testing","volume":"48","author":"SY Rhee","year":"2004","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"pgen.1009009.ref070","unstructured":"HIV Databases;. Available from: http:\/\/www.hiv.lanl.gov\/."},{"issue":"4","key":"pgen.1009009.ref071","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1093\/molbev\/msz022","article-title":"Constrained mutational sampling of amino acids in HIV-1 protease evolution","volume":"36","author":"JI Boucher","year":"2019","journal-title":"Molecular biology and evolution"},{"issue":"2","key":"pgen.1009009.ref072","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/molbev\/msl168","article-title":"HIV-1 protease catalytic efficiency effects caused by random single amino acid substitutions","volume":"24","author":"M Parera","year":"2006","journal-title":"Molecular Biology and Evolution"},{"issue":"6","key":"pgen.1009009.ref073","first-page":"e01050","article-title":"Effects of mutations on replicative fitness and major histocompatibility complex class I binding affinity are among the determinants underlying cytotoxic-T-lymphocyte escape of HIV-1 gag epitopes","volume":"8","author":"Y Du","year":"2017","journal-title":"mBio"},{"issue":"1","key":"pgen.1009009.ref074","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s12977-014-0124-6","article-title":"High-throughput profiling of point mutations across the HIV-1 genome","volume":"11","author":"LQ Al-Mawsawi","year":"2014","journal-title":"Retrovirology"},{"issue":"43","key":"pgen.1009009.ref075","doi-asserted-by":"crossref","first-page":"15376","DOI":"10.1073\/pnas.0404125101","article-title":"The contribution of epistasis to the architecture of fitness in an RNA virus","volume":"101","author":"R Sanjuan","year":"2004","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"4","key":"pgen.1009009.ref076","doi-asserted-by":"crossref","first-page":"e94","DOI":"10.1371\/journal.pbio.0050094","article-title":"Understanding the evolutionary fate of finite populations: the dynamics of mutational effects","volume":"5","author":"OK Silander","year":"2007","journal-title":"PLoS Biology"},{"key":"pgen.1009009.ref077","article-title":"Quantifying the evolutionary potential and constraints of a drug-targeted viral protein","author":"L Dai","year":"2016","journal-title":"bioRxiv"},{"issue":"6","key":"pgen.1009009.ref078","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1093\/molbev\/msu113","article-title":"Strong epistatic interactions within a single protein","volume":"31","author":"M Parera","year":"2014","journal-title":"Molecular Biology and Evolution"},{"issue":"6034","key":"pgen.1009009.ref079","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1126\/science.1203801","article-title":"Negative epistasis between beneficial mutations in an evolving bacterial population","volume":"332","author":"AI Khan","year":"2011","journal-title":"Science"},{"issue":"5","key":"pgen.1009009.ref080","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/PL00000082","article-title":"Little evidence for synergism among deleterious mutations in a nonsegmented RNA virus","volume":"49","author":"SF Elena","year":"1999","journal-title":"Journal of Molecular Evolution"},{"issue":"5","key":"pgen.1009009.ref081","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1084\/jem.20072457","article-title":"Transmission of HIV-1 Gag immune escape mutations is associated with reduced viral load in linked recipients","volume":"205","author":"PA Goepfert","year":"2008","journal-title":"Journal of Experimental Medicine"},{"issue":"18","key":"pgen.1009009.ref082","doi-asserted-by":"crossref","first-page":"8316","DOI":"10.1128\/JVI.74.18.8316-8323.2000","article-title":"Response of foot-and-mouth disease virus to increased mutagenesis: influence of viral load and fitness in loss of infectivity","volume":"74","author":"S Sierra","year":"2000","journal-title":"Journal of Virology"},{"issue":"6944","key":"pgen.1009009.ref083","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature01707","article-title":"The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA","volume":"424","author":"H Zhang","year":"2003","journal-title":"Nature"},{"issue":"6","key":"pgen.1009009.ref084","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0092-8674(03)00423-9","article-title":"DNA deamination mediates innate immunity to retroviral infection","volume":"113","author":"RS Harris","year":"2003","journal-title":"Cell"},{"issue":"6944","key":"pgen.1009009.ref085","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature01709","article-title":"Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts","volume":"424","author":"B Mangeat","year":"2003","journal-title":"Nature"},{"issue":"12","key":"pgen.1009009.ref086","doi-asserted-by":"crossref","first-page":"6895","DOI":"10.1073\/pnas.111085598","article-title":"RNA virus error catastrophe: direct molecular test by using ribavirin","volume":"98","author":"S Crotty","year":"2001","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"3","key":"pgen.1009009.ref087","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.immuni.2012.11.022","article-title":"Translating HIV sequences into quantitative fitness landscapes predicts viral vulnerabilities for rational immunogen design","volume":"38","author":"AL Ferguson","year":"2013","journal-title":"Immunity"},{"issue":"8","key":"pgen.1009009.ref088","first-page":"1","article-title":"The Fitness Landscape of HIV-1 Gag: Advanced Modeling Approaches and Validation of Model Predictions by In Vitro Testing","volume":"10","author":"JK Mann","year":"2014","journal-title":"PLOS Computational Biology"},{"issue":"2","key":"pgen.1009009.ref089","doi-asserted-by":"crossref","first-page":"022412","DOI":"10.1103\/PhysRevE.93.022412","article-title":"Identification of drug resistance mutations in HIV from constraints on natural evolution","volume":"93","author":"TC Butler","year":"2016","journal-title":"Physical Review E"},{"issue":"4","key":"pgen.1009009.ref090","doi-asserted-by":"crossref","first-page":"E564","DOI":"10.1073\/pnas.1717765115","article-title":"Fitness landscape of the human immunodeficiency virus envelope protein that is targeted by antibodies","volume":"115","author":"RH Louie","year":"2018","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"20","key":"pgen.1009009.ref091","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1093\/bioinformatics\/btw328","article-title":"ACE: adaptive cluster expansion for maximum entropy graphical model inference","volume":"32","author":"JP Barton","year":"2016","journal-title":"Bioinformatics"},{"issue":"3","key":"pgen.1009009.ref092","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1128\/JVI.01635-10","article-title":"RIG-I-mediated antiviral signaling is inhibited in HIV-1 infection by a protease-mediated sequestration of RIG-I","volume":"85","author":"M Solis","year":"2011","journal-title":"Journal of Virology"},{"issue":"25","key":"pgen.1009009.ref093","doi-asserted-by":"crossref","first-page":"E3226","DOI":"10.1073\/pnas.1412933112","article-title":"Contingency and entrenchment in protein evolution under purifying selection","volume":"112","author":"P Shah","year":"2015","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"11","key":"pgen.1009009.ref094","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1111\/evo.12192","article-title":"Selection biases the prevalence and type of epistasis along adaptive trajectories","volume":"67","author":"JA Draghi","year":"2013","journal-title":"Evolution"},{"key":"pgen.1009009.ref095","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.tpb.2016.08.001","article-title":"Estimation of the HIV-1 backward mutation rate from transmitted drug-resistant strains","volume":"112","author":"JM Kitayimbwa","year":"2016","journal-title":"Theoretical Population Biology"},{"issue":"6","key":"pgen.1009009.ref096","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1086\/432916","article-title":"Prevalence of Drug-Resistant HIV-1 Variants in Untreated Individuals in Europe: Implications for Clinical Management","volume":"192","author":"AJ Wensing","year":"2005","journal-title":"The Journal of Infectious Diseases"},{"issue":"4882","key":"pgen.1009009.ref097","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1126\/science.2460925","article-title":"The accuracy of reverse transcriptase from HIV-1","volume":"242","author":"JD Roberts","year":"1988","journal-title":"Science"},{"issue":"9","key":"pgen.1009009.ref098","doi-asserted-by":"crossref","first-page":"e1002251","DOI":"10.1371\/journal.pbio.1002251","article-title":"Extremely high mutation rate of HIV-1 in vivo","volume":"13","author":"JM Cuevas","year":"2015","journal-title":"PLoS Biology"},{"issue":"6","key":"pgen.1009009.ref099","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1186\/gb-2010-11-6-r60","article-title":"Global fitness profiling of fission yeast deletion strains by barcode sequencing","volume":"11","author":"TX Han","year":"2010","journal-title":"Genome biology"},{"issue":"10","key":"pgen.1009009.ref100","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nmeth.1377","article-title":"Tn-seq: high-throughput parallel sequencing for fitness and genetic interaction studies in microorganisms","volume":"6","author":"T Van Opijnen","year":"2009","journal-title":"Nature methods"},{"issue":"5255","key":"pgen.1009009.ref101","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1126\/science.271.5255.1582","article-title":"HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time","volume":"271","author":"AS Perelson","year":"1996","journal-title":"Science"},{"issue":"7","key":"pgen.1009009.ref102","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/j.cell.2016.11.031","article-title":"Functional segregation of overlapping genes in HIV","volume":"167","author":"JD Fernandes","year":"2016","journal-title":"Cell"},{"issue":"5","key":"pgen.1009009.ref103","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/BF00216965","article-title":"Fourier and Taylor series on fitness landscapes","volume":"65","author":"ED Weinberger","year":"1991","journal-title":"Biological cybernetics"},{"issue":"13","key":"pgen.1009009.ref104","doi-asserted-by":"crossref","first-page":"E2662","DOI":"10.1073\/pnas.1615068114","article-title":"Large-scale identification of coevolution signals across homo-oligomeric protein interfaces by direct coupling analysis","volume":"114","author":"G Uguzzoni","year":"2017","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"pgen.1009009.ref105","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.sbi.2016.11.004","article-title":"Potts Hamiltonian models of protein co-variation, free energy landscapes, and evolutionary fitness","volume":"43","author":"RM Levy","year":"2017","journal-title":"Current opinion in structural biology"},{"issue":"7","key":"pgen.1009009.ref106","doi-asserted-by":"crossref","first-page":"3722","DOI":"10.1128\/JVI.78.7.3722-3732.2004","article-title":"Positive selection detection in 40,000 human immunodeficiency virus (HIV) type 1 sequences automatically identifies drug resistance and positive fitness mutations in HIV protease and reverse transcriptase","volume":"78","author":"L Chen","year":"2004","journal-title":"Journal of Virology"},{"issue":"3","key":"pgen.1009009.ref107","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/ng.524","article-title":"Prevalent positive epistasis in Escherichia coli and Saccharomyces cerevisiae metabolic networks","volume":"42","author":"X He","year":"2010","journal-title":"Nature genetics"},{"issue":"9180","key":"pgen.1009009.ref108","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0140-6736(98)12262-6","article-title":"Transmission of antiretroviral-drug-resistant HIV-1 variants","volume":"354","author":"S Yerly","year":"1999","journal-title":"The Lancet"},{"issue":"7121","key":"pgen.1009009.ref109","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/nature05385","article-title":"Robustness\u2013epistasis link shapes the fitness landscape of a randomly drifting protein","volume":"444","author":"S Bershtein","year":"2006","journal-title":"Nature"},{"issue":"3","key":"pgen.1009009.ref110","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1002\/prot.22921","article-title":"Role of conformational sampling in computing mutation-induced changes in protein structure and stability","volume":"79","author":"EH Kellogg","year":"2011","journal-title":"Proteins: Structure, Function, and Bioinformatics"},{"key":"pgen.1009009.ref111","doi-asserted-by":"crossref","first-page":"11660","DOI":"10.1038\/ncomms11660","article-title":"Relative rate and location of intra-host HIV evolution to evade cellular immunity are predictable","volume":"7","author":"JP Barton","year":"2016","journal-title":"Nature Communications"}],"updated-by":[{"DOI":"10.1371\/journal.pgen.1009009","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T00:00:00Z","timestamp":1604275200000}}],"container-title":["PLOS Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgen.1009009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T00:11:44Z","timestamp":1669248704000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pgen.1009009"}},"subtitle":[],"editor":[{"given":"Jianzhi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,10,21]]},"references-count":111,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pgen.1009009","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/822981","asserted-by":"object"}]},"ISSN":["1553-7404"],"issn-type":[{"value":"1553-7404","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,21]]}}}